School Of Pharmacy Arka jain University, hiring freshers & experience for Professors/ Associate Professors ||15nos. of post Vacancy

School Of Pharmacy Arka jain University, hiring freshers & experience for Professors/ Associate Professors ||15nos. of post Vacancy

School Of Pharmacy Arka jain University JAMSHEDPUR Jharkhand

Urgently required for 15nos. of post Vacancy – Apply Now
Recruitment for the Post of

1.Professor’s

2.Associate Professors or

3.Assistant Professors

freshers/Experience

Qualification : M pharm /phd

Salary : Negotiable

Note : Please mentioned the name of the positions in the subject line of email when you apply.

Interested candidates should E-Mail Resume to [email protected]

Or Anyone interested then kindly contact with 7008667244 .

• Granules India Walk-In Interview on 14 May 2025 for API Production & SRS Roles
  Granules India Limited is a leading Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana. Established in 1984 as Triton Laboratories, the company initially focused on producing Paracetamol API. In 1991, it was rebranded as Granules India Limited and has since… Read more: Granules India Walk-In Interview on 14 May 2025 for API Production & SRS Roles
• FDA approves nivolumab with ipilimumab for unresectable or metastatic MSI-H or dMMR colorectal cancer
  The Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with ipilimumab (Yervoy, Bristol Myers Squibb Company) for adult and pediatric patients 12 years of age and older with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair… Read more: FDA approves nivolumab with ipilimumab for unresectable or metastatic MSI-H or dMMR colorectal cancer
• Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
  Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), determined by the FDA to be bioequivalent1to Pataday®2 Once Daily Relief Ophthalmic Solution,… Read more: Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
• FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
  The U.S. Food and Drug Administration announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for American consumers and patients. This change builds upon the… Read more: FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
• Vital Therapeutics Freshers & Experts walk in for RO/DM Plant Operators, & Production Chemists | 10th May
  Based in Hyderabad, Telangana, Vital Therapeutics & Formulations Pvt. Ltd. is a pharmaceutical manufacturing company established in 2004. With over 25 years of expertiseContentsRequirement Details:Walk in interview details: Vital Therapeutics and Formulations – Walk in Interviews for RO, DM Plant… Read more: Vital Therapeutics Freshers & Experts walk in for RO/DM Plant Operators, & Production Chemists | 10th May